Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2021 Q4
17 of 19 quarters
Total Value
$41.37M
Total Shares
1.89M
Net Share Change
+234.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$41.37M
1.89M
0.5%
ADD
+234.8K
(+14.1%)
Maverick Capital
$41.37M
1.89M shares
ADD
+234.8K
(+14.1%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy